What's new

Human medicines European public assessment report (EPAR): Bekemv, eculizumab, Date of authorisation: 19/04/2023, Revision: 4, Status: Authorised

Human medicines European public assessment report (EPAR): Bekemv, eculizumab, Date of authorisation: 19/04/2023, Revision: 4, Status: Authorised

May 2, 2025 - 15:12
 0
Human medicines European public assessment report (EPAR): Bekemv, eculizumab, Date of authorisation: 19/04/2023, Revision: 4, Status: Authorised
Human medicines European public assessment report (EPAR): Bekemv, eculizumab, Date of authorisation: 19/04/2023, Revision: 4, Status: Authorised
Read More

Tags:

Previous Article

Human medicines European public assessment report (EPAR): Beyfortus, nirsevimab,...

Next Article

Tsingtao adds 24-ounce can for Premium Lager

Related Posts

Article 57 product data

Apr 26, 2025  0

List of eligible industry stakeholder organisations

Apr 29, 2025  0

EudraVigilance Expert Working Group (EV-EWG) work progr...

Apr 28, 2025  0